A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine
Clinical trial NCT03988088 · COMPLETED
Trial details
- NCT number
- NCT03988088
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-22
- Primary completion
- 2020-01-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.